- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives for therapy of treatment‐resistant depression
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-06-15
DOI
10.1111/bph.15596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- NLX-101, a cortical 5-HT1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition
- (2021) Ronan Yves Depoortere et al. BRAIN RESEARCH
- The identification, assessment and management of difficult-to-treat depression: An international consensus statement
- (2020) R.H. McAllister-Williams et al. JOURNAL OF AFFECTIVE DISORDERS
- Pharmacological Treatments for Patients with Treatment-Resistant Depression
- (2020) Valerie L. Ruberto et al. Pharmaceuticals
- Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile
- (2020) Joanna Sniecikowska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial
- (2020) Monika Dominiak et al. JOURNAL OF PSYCHIATRIC RESEARCH
- AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats
- (2020) Mariusz Papp et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?
- (2020) Seetal Dodd et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
- (2019) Brendan D. Hare et al. Nature Communications
- Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine
- (2019) Tak Youn et al. PSYCHIATRY RESEARCH
- Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
- (2019) Thu Ha Pham et al. PHARMACOLOGY & THERAPEUTICS
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression
- (2019) Mariusz Papp et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity
- (2019) Joanna Sniecikowska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coping with the forced swim stressor: Current state-of-the-art
- (2019) Marc L. Molendijk et al. BEHAVIOURAL BRAIN RESEARCH
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress Model
- (2019) Gehua Wen et al. Frontiers in Psychiatry
- Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model
- (2019) Ronan Depoortère et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
- (2019) Bing Cao et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice
- (2019) Lucie Bartova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- 18F-F13640 PET imaging of functional receptors in humans
- (2019) Matthieu Colom et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review
- (2019) Tom Biselli et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists
- (2019) Benjamin Vidal et al. NEUROPHARMACOLOGY
- Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response
- (2019) Lily R. Aleksandrova et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex
- (2019) Mariusz Papp et al. NEUROSCIENCE
- Optogenetics: What it has uncovered in potential pathways of depression
- (2019) Ziqian Cheng et al. PHARMACOLOGICAL RESEARCH
- Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
- (2019) Satoshi Deyama et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Activation of 5-HT1A postsynaptic receptors by NLX-101 results in functional recovery and an increase in neuroplasticity in mice with brain ischemia
- (2019) Rafael Pazinatto Aguiar et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events
- (2018) Amanda L. Maciel et al. BRAIN RESEARCH BULLETIN
- A systematic review and meta-analysis of deep brain stimulation for depression
- (2018) Steve Kisely et al. DEPRESSION AND ANXIETY
- Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
- (2018) Patricio Riva-Posse et al. JOURNAL OF AFFECTIVE DISORDERS
- 5-HT 6 receptor agonist and memory-enhancing properties of hypidone hydrochloride (YL-0919), a novel 5-HT 1A receptor partial agonist and SSRI
- (2018) Xiao-fei Chen et al. NEUROPHARMACOLOGY
- In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging
- (2018) Benjamin Vidal et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine-induced neurotoxicity blocked by N -Methyl- d -aspartate is mediated through activation of PKC/ERK pathway in developing hippocampal neurons
- (2018) Sufang Jiang et al. NEUROSCIENCE LETTERS
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Are there clinical and neurophysiologic predictive factors for a positive response to HF-rTMS in patients with treatment-resistant depression?
- (2018) Anna Poleszczyk et al. PSYCHIATRY RESEARCH
- Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression
- (2018) Paul Willner et al. BEHAVIOURAL PHARMACOLOGY
- Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression
- (2018) Mariusz Papp et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex
- (2018) Hyeonwi Son et al. NEUROPHARMACOLOGY
- Serotonin 5-HT1A Receptor Biased Agonists Induce Different Cerebral Metabolic Responses: A [18F]-Fluorodesoxyglucose Positron Emission Tomography Study in Conscious and Anesthetized Rats
- (2018) Elise Levigoureux et al. ACS Chemical Neuroscience
- Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
- (2018) A. Kautzky et al. ACTA PSYCHIATRICA SCANDINAVICA
- The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology
- (2018) Emily L. Belleau et al. BIOLOGICAL PSYCHIATRY
- Chronic Unpredictable Mild Stress for Modeling Depression in Rodents:Meta-analysis of Model Reliability
- (2018) Svitlana Antoniuk et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Definition of treatment-resistant depression – Asia Pacific perspectives
- (2018) C.H. Ng et al. JOURNAL OF AFFECTIVE DISORDERS
- Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
- (2017) Kenichi Fukumoto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist
- (2017) Adrian Newman-Tancredi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
- (2017) Lily R. Aleksandrova et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Impact of STN-DBS on mood, drive, anhedonia and risk of psychiatric side-effects in the population of PD patients
- (2017) Anna Antosik-Wójcińska et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Anesthetics inhibit extracellular signal-regulated Kinase1/2 phosphorylation via NMDA receptor, phospholipase C and protein kinase C in mouse hippocampal slices
- (2017) Gao Haiying et al. NEUROCHEMISTRY INTERNATIONAL
- P.2.015 Chronic effects of ‘biased’ 5-HT1A receptor agonists on object pattern separation performance and hippocampal plasticity
- (2016) B. Van Hagen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A sham-controlled randomized trial of adjunctive light therapy for non-seasonal depression
- (2016) Magdalena Chojnacka et al. JOURNAL OF AFFECTIVE DISORDERS
- Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change
- (2016) George I. Papakostas JOURNAL OF CLINICAL PSYCHIATRY
- Representations of ECT in English-Language Film and Television in the New Millennium
- (2016) Avery Madeleine Matthews et al. JOURNAL OF ECT
- Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex
- (2016) Laura Jiménez-Sánchez et al. NEUROPHARMACOLOGY
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The efficacy and safety of ECT in population before and after 60 years of age
- (2016) Anna Antosik-Wójcińska et al. Psychiatria Polska
- Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study
- (2016) G. Becker et al. Scientific Reports
- Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression
- (2016) Isidoor O. Bergfeld et al. JAMA Psychiatry
- Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder
- (2016) Raymond W. Lam et al. JAMA Psychiatry
- A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression
- (2015) Darin D. Dougherty et al. BIOLOGICAL PSYCHIATRY
- Divergent effects of the ‘biased’ 5-HT1Areceptor agonists F15599 and F13714 in a novel object pattern separation task
- (2015) N P van Goethem et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of AMPA Receptors Mediates the Antidepressant Action of Deep Brain Stimulation of the Infralimbic Prefrontal Cortex
- (2015) Laura Jiménez-Sánchez et al. CEREBRAL CORTEX
- Bright white light therapy in depression: A critical review of the evidence
- (2015) Björn Mårtensson et al. JOURNAL OF AFFECTIVE DISORDERS
- Activation of a ventral hippocampus–medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine
- (2015) F R Carreno et al. MOLECULAR PSYCHIATRY
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The use of DBS stimulation in mental disorders - opportunities and risks.
- (2015) Anna Antosik-Wójcińska et al. Psychiatria Polska
- Treatment-resistant depression: are animal models of depression fit for purpose?
- (2015) Paul Willner et al. PSYCHOPHARMACOLOGY
- Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression
- (2015) Rosemary C. Bagot et al. Nature Communications
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Electrical stimulation alleviates depressive-like behaviors of rats: investigation of brain targets and potential mechanisms
- (2015) L W Lim et al. Translational Psychiatry
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant-like Effects of Cortical Deep Brain Stimulation Coincide With Pro-neuroplastic Adaptations of Serotonin Systems
- (2014) Avin Veerakumar et al. BIOLOGICAL PSYCHIATRY
- Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice
- (2014) Ryota Araki et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prefrontal Cortical Circuit for Depression- and Anxiety-Related Behaviors Mediated by Cholecystokinin: Role of FosB
- (2014) V. Vialou et al. JOURNAL OF NEUROSCIENCE
- MAPK signaling correlates with the antidepressant effects of ketamine
- (2014) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
- (2014) H Yamanaka et al. Translational Psychiatry
- Pretreatment Brain States Identify Likely Nonresponse to Standard Treatments for Depression
- (2013) Callie L. McGrath et al. BIOLOGICAL PSYCHIATRY
- Prevalence of treatment-resistant depression in primary care: cross-sectional data
- (2013) Laura Thomas et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
- (2013) Pau Celada et al. CNS DRUGS
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys
- (2013) Shigeyuki Yamamoto et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
- (2013) Valentina Gigliucci et al. PSYCHOPHARMACOLOGY
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- (2013) Alize J. Ferrari et al. PLOS MEDICINE
- Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy
- (2012) James Craig Nelson et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Neurobiology of chronic mild stress: Parallels to major depression
- (2012) Matthew N. Hill et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The neurobiology of depression and antidepressant action
- (2012) Paul Willner et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Deep brain stimulation in treatment-resistant depression in mice: Comparison with the CRF1 antagonist, SSR125543
- (2012) Carine Dournes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
- (2012) M. Horiguchi et al. PSYCHOPHARMACOLOGY
- Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders
- (2012) Adrian Newman-Tancredi Neuropsychiatry
- Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years
- (2011) Sidney H. Kennedy et al. AMERICAN JOURNAL OF PSYCHIATRY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Role of Serotonin and Brain Derived Neurotrophic Factor
- (2011) Clement Hamani et al. BIOLOGICAL PSYCHIATRY
- 5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons
- (2011) L. Llado-Pelfort et al. CEREBRAL CORTEX
- The size and burden of mental disorders and other disorders of the brain in Europe 2010
- (2011) H.U. Wittchen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment-Resistant Depression
- (2011) Michael E. Thase JOURNAL OF CLINICAL PSYCHIATRY
- The Effects of Fluoxetine Treatment in a Chronic Mild Stress Rat Model on Depression-Related Behavior, Brain Neurotrophins and ERK Expression
- (2011) Maya First et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: A report of 3 cases
- (2011) Ingeborg M. Noppers et al. PAIN
- In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
- (2011) Laia Lladó-Pelfort et al. PSYCHOPHARMACOLOGY
- The Subcallosal Cingulate Gyrus in the Context of Major Depression
- (2010) Clement Hamani et al. BIOLOGICAL PSYCHIATRY
- Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors
- (2010) L Lladó-Pelfort et al. BRITISH JOURNAL OF PHARMACOLOGY
- F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists
- (2010) Ronan Depoortère et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity
- (2010) Marie-Bernadette Assié et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant Pharmacotherapy Failure and Response to Subsequent Electroconvulsive Therapy
- (2010) Willemijn T. Heijnen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex
- (2010) H. E. Covington et al. JOURNAL OF NEUROSCIENCE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1Areceptor agonist
- (2009) A Newman-Tancredi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1)
- (2009) Yogesh Dwivedi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Targeted electrode-based modulation of neural circuits for depression
- (2009) Helen S. Mayberg JOURNAL OF CLINICAL INVESTIGATION
- Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
- (2008) Andres M. Lozano et al. BIOLOGICAL PSYCHIATRY
- Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: A quantitative ELISA study
- (2008) Jaroslava Buritova et al. NEUROPHARMACOLOGY
- Potential surgical targets for deep brain stimulation in treatment-resistant depression
- (2008) Jason S. Hauptman et al. Neurosurgical Focus
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started